Pharmacology & Pharmaceutics | All Life | Taylor & Francis

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Pharmacology & Pharmaceutics

All Life

The Pharmacology and Pharmaceutics Section of All Life is seeking submissions across the fields of experimental and clinical pharmacology.

This section of All Life includes:

Experimental Pharmacology

Clinical Pharmacology

Pharmacokinetics

Pharmacodynamics

Therapeutic Drug Monitoring

Drug Safety

Drug Design

Pharmaceutics

Biopharmaceutics

Molecular Modelling

Drug Targeting

Pharmaceutical Nanotechnology

2020 Impact Factor: 2.000

Five-Year Impact Factor: 4.888

WEB OF SCIENCE® Indexed

235k Annual Article Downloads

All Life is linked with the UN’s Sustainable Development Goals. We invite you to share research and data towards Goal 3: Good Health and Well-being.

Meet the Section Editor

Editorial board for All Life

Stefania Nobili, University of Chieti-Pescara, Italy

Dr. Nobili is an Assistant Professor at the Department of Neurosciences, Imaging and Clinical Sciences of the “G. d’Annunzio” University of Chieti-Pescara, Italy. She received her Pharm.D. degree from the University of Rome ‘La Sapienza’ in 1989, her specialization in Applied Pharmacology from the University of Florence in 1997, and her Ph.D. in Chemotherapy from the University of Milan in 2001. In 2013, she was awarded the Alberico Benedicenti Award for Pharmacology and Toxicology from the Italian Society of Pharmacology. From 2007 to 2019 she worked as Assistant Professor at the University of Florence (Italy). Her research interests are focused on preclinical and clinical pharmacology of anticancer drugs, in particular cancer pharmacogenetics and pharmacogenomics, tumor drug resistance, with emphasis on drugs used in the treatment of gastrointestinal neoplasms.

Publicly Available Data Sharing Policy

Authors are required to make supporting data and materials freely available before submission in a suitable repository under any Creative Commons license. You will be prompted to provide a data availability statement with your submission.

LEARN MORE

Why Submit to All Life?

  • Increase the visibility and readership of your research by publishing in a fully open access journal with a wide international readership.

  • Grow your real-world impact by publishing in a journal supporting the UN's Sustainable Development Goals to reach policymakers and professionals who are tackling today’s problems.

  • Find a home for your research with our broad aims and scope welcoming truly multidisciplinary research, publishing all scientifically valid research including reporting of negative and null data, replication and reproduction studies.

  • Get up to 25% more citations through the public availability of all data associated with submissions.*

  • Benefit from format-free submission and a rigorous peer review process led by our team of subject experts across specialty sections.

  • Indexed in the Multidisciplinary Sciences JCR category and by EBSCOhost, Academic Search Complete, TOC Premier (Table of Contents), OCLC, Arts and Humanities Search, Ovid, Inspec, and Science Citation Index Expanded (Web of Science).

 Submit Now   Instructions For Authors

 

*The State of Open Data Report 2019

Understanding Research Data

Our guide explains the benefits of data sharing and will help you understand the steps you’ll need to take as an author to comply with data sharing policies.
Read the guide

Good editing leads to a great manuscript

Taylor & Francis offers a range of pre-submission manuscript preparation services, including English-language editing.
FIND OUT MORE

Get more from your data set with data notes

Increase the discoverability of your research and gain extra credit for your work when you publish a data note in All Life.
LEARN MORE